Neovascular Age-related Macular Degeneration of All Subtypes
1 clinical trials · Condition
◉ Watch Neovascular Age-related Macular Degeneration of All Subtypes
| Record | Firm | Date |
|---|---|---|
| Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START (NCT02246829) | University Hospital, Bordeaux | 2014-09-01 |
Track Neovascular Age-related Macular Degeneration of All Subtypes automatically
Every clearance here is in the API, with alerts when new ones post.